VERU INC. Preferred Stock, Par or Stated Value Per Share
VERU INC. (VERU) had Preferred Stock, Par or Stated Value Per Share of $0.50 per share as of 2013-09-30, per its 10-K filed 2013-12-03.
Discontinued › Balance Sheet › Equity › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockParOrStatedValuePerShare · last filed 2013-12-03
- 2013-09-30: Preferred Stock, Par or Stated Value Per Share $0.50.
| Period end | Preferred Stock, Par or Stated Value Per Share |
|---|---|
| 2013-09-30 | $0.50 10-K · filed 2013-12-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |